The cannabis-oriented health and wellness company noted that by leveraging this patent, it aims to pursue licensing opportunities for its unique extraction process with manufacturers.  

"Building out a comprehensive IP portfolio is an important strategy to unlock durable growth drivers for Neptune,” Michael Cammarata, president and CEO of Neptune Wellness, said in a statement. “Our differentiated extraction process was developed through years of science-backed research and represents the continued progress of our IP strategy."

Price Action

Neptune Wellness’ shares were trading 1.16% higher at 54 cents per share at the time of writing Thursday morning.

Photo: Courtesy of CRYSTALWEED cannabis on Unsplash